Wednesday, January 19, 2022

CDSCO

CDSCO approves 2 new Covid vaccines, 1 anti-viral drug for restricted use

New Delhi: Amid the ongoing resurgence of new Covid-19 cases in the country, an expert panel of the Central Drugs Standard Control Organisation has...

Open vial of Covaxin stable at 2-8°C for up to 28 days: Bharat Biotech

Hyderabad: Explaining its 28 days open vial policy, Hyderabad-based Bharat Biotech on Monday stated that healthcare workers do not have to worry about opening...

CDSCO approves extension of shelf life of Covaxin to 12 months

Hyderabad: The shelf life of Hyderabad-based Bharat Biotech’s Covid-19 vaccine, Covaxin, has been extended to 12 months from the present nine months by the...

India’s drug regulator approves study on mixing of Covaxin and Covishield doses

An expert panel of the Central Drugs Standard Control Organisation (CDSCO) on July 29 had recommended granting permission for conducting the study.

One batch of Covaxin takes four months to manufacture and release

For vaccines to result in actual vaccination of people, highly coordinated efforts are required from international supply chains, manufacturers, regulators and State and Central government agencies, says Bharat Biotech

Roche’s antibody Covid drug now available in India

Roche is deeply committed to support the ongoing efforts to combat the Covid-19 pandemic, mitigate the deadly second wave and save lives

Covaxin emergency use authorisation approval a significant landmark: Dr Ella

While this vaccine addresses an unmet medical need during this pandemic, our goal is to provide global access to populations that need it the most. Covaxin has generated excellent safety data with robust immune responses

SII’s application for Covid vax emergency approval to be considered on Wednesday

The development came after the UK became the first country in the world to approve a coronavirus vaccine developed by Oxford University and AstraZeneca, even as it battled the new highly contagious variant of the coronavirus.

Latest News

- Advertisement -